Jason M. Redman

1.8k total citations
53 papers, 1.0k citations indexed

About

Jason M. Redman is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jason M. Redman has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 26 papers in Immunology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jason M. Redman's work include Cancer Immunotherapy and Biomarkers (31 papers), Immunotherapy and Immune Responses (22 papers) and Prostate Cancer Treatment and Research (12 papers). Jason M. Redman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (31 papers), Immunotherapy and Immune Responses (22 papers) and Prostate Cancer Treatment and Research (12 papers). Jason M. Redman collaborates with scholars based in United States, Germany and France. Jason M. Redman's co-authors include James L. Gulley, Julie Collins, Geoffrey T. Gibney, Michael B. Atkins, Louis M. Weiner, Margaret E. Gatti‐Mays, Dalal Aldeghaither, Elizabeth Hill, Marijo Bilušić and Ravi A. Madan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Jason M. Redman

49 papers receiving 1.0k citations

Peers

Jason M. Redman
Michelle L. Badura United States
Pedro M. Sousa Alves France
Bianca von Scheidt Australia
Stéphanie Corgnac France
Cinzia Remondo Italy
Yann Godet France
Fumiaki Nakayama Japan
Huihua Zhang China
Srinivas Mamidi Germany
Jennifer N. Durham United States
Michelle L. Badura United States
Jason M. Redman
Citations per year, relative to Jason M. Redman Jason M. Redman (= 1×) peers Michelle L. Badura

Countries citing papers authored by Jason M. Redman

Since Specialization
Citations

This map shows the geographic impact of Jason M. Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Redman more than expected).

Fields of papers citing papers by Jason M. Redman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason M. Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Redman. The network helps show where Jason M. Redman may publish in the future.

Co-authorship network of co-authors of Jason M. Redman

This figure shows the co-authorship network connecting the top 25 collaborators of Jason M. Redman. A scholar is included among the top collaborators of Jason M. Redman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason M. Redman. Jason M. Redman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bracken‐Clarke, Dara, Danielle M. Pastor, Jennifer L. Marté, et al.. (2026). The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer. The Oncologist. 31(3).
2.
Floudas, Charalampos S., Meghali Goswami, Renee N. Donahue, et al.. (2025). Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers. JAMA Oncology. 11(4). 394–394. 10 indexed citations
3.
Bracken‐Clarke, Dara, Clint Allen, Elisabetta Xue, et al.. (2024). Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS6124–TPS6124.
4.
5.
Robbins, Yvette, Jay Friedman, Jason M. Redman, et al.. (2023). Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer. Oral Oncology. 138. 106309–106309. 6 indexed citations
6.
Gatti‐Mays, Margaret E., Nicholas Tschernia, Julius Strauss, et al.. (2023). A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors. The Oncologist. 28(4). 364–e217. 9 indexed citations
7.
8.
Redman, Jason M., Geraldine O’Sullivan Coyne, Ravi A. Madan, et al.. (2023). Avelumab in Patients With Metastatic Colorectal Cancer. The Oncologist. 28(9). 823–e804. 4 indexed citations
9.
Redman, Jason M., Benjamin A. Weinberg, Renee N. Donahue, et al.. (2022). A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer. The Oncologist. 27(3). 198–209. 30 indexed citations
10.
Bilušić, Marijo, Sheri McMahon, Ravi A. Madan, et al.. (2021). Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for ImmunoTherapy of Cancer. 9(3). e002374–e002374. 43 indexed citations
11.
Strauss, Julius, Margaret E. Gatti‐Mays, Byoung Chul Cho, et al.. (2021). 957O Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1. Annals of Oncology. 32. S829–S829. 5 indexed citations
12.
13.
Gatti‐Mays, Margaret E., Julius Strauss, Renee N. Donahue, et al.. (2019). A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules. Clinical Cancer Research. 25(16). 4933–4944. 45 indexed citations
14.
Redman, Jason M., Alessandra Brofferio, James L. Gulley, et al.. (2019). Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion. Journal of Gastrointestinal Oncology. 10(5). 1010–1014. 8 indexed citations
15.
Redman, Jason M., Lisa M. Cordes, Helen Owens, et al.. (2019). A Case of Anti–PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema. Clinical Genitourinary Cancer. 17(3). e549–e552. 4 indexed citations
16.
Redman, Jason M., Seth M. Steinberg, & James L. Gulley. (2018). Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer. Journal for ImmunoTherapy of Cancer. 6(1). 91–91. 44 indexed citations
17.
Gatti‐Mays, Margaret E., Jason M. Redman, Julie Collins, & Marijo Bilušić. (2017). Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations. Human Vaccines & Immunotherapeutics. 13(11). 2561–2574. 80 indexed citations
18.
Redman, Jason M., Geoffrey T. Gibney, & Michael B. Atkins. (2016). Advances in immunotherapy for melanoma. BMC Medicine. 14(1). 20–20. 105 indexed citations
19.
Lee, Young‐Tae, et al.. (2009). CD69 and CD103 cooperatively regulate CD8 T cell responses in the lungs after viral infection (39.25). The Journal of Immunology. 182(Supplement_1). 39.25–39.25. 2 indexed citations
20.
Redman, Jason M., et al.. (2002). Abiotic and biotic stress differentially stimulate as-1 element activity in Arabidopsis. Plant Cell Reports. 21(2). 180–185. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle L. Badura Breakdown of academic impact, for papers by Pedro M. Sousa Alves Breakdown of academic impact, for papers by Bianca von Scheidt Breakdown of academic impact, for papers by Stéphanie Corgnac Breakdown of academic impact, for papers by Cinzia Remondo Breakdown of academic impact, for papers by Yann Godet Breakdown of academic impact, for papers by Fumiaki Nakayama Breakdown of academic impact, for papers by Huihua Zhang Breakdown of academic impact, for papers by Srinivas Mamidi Breakdown of academic impact, for papers by Jennifer N. Durham
Rankless by CCL
2026